QOP
CERE

Quinn Opportunity Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quinn Opportunity Partners’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,000
Closed -$204K – 348
2024
Q2 		$204K Buy
+5,000
New +$208K 0.02% 229

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Quinn Opportunity Partners's CERE Position: Q3 2024 in Review

Quinn Opportunity Partners sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,000 shares — an estimated $204K sold.

Quinn Opportunity Partners first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $204K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Quinn Opportunity Partners reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Quinn Opportunity Partners sold 5,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $204K.
  • Quinn Opportunity Partners first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Quinn Opportunity Partners's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $204K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Quinn Opportunity Partners's 13F filing for Q3 2024, filed 13 Nov 2024.